ASX Company Announcements


The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange.


16 Dec 2011 

 Appendix 3B

 08 Dec 2011

 Notice of Initial Substantial Holder

 08 Dec 2011

 Change of Director's Interest Notice

 08 Dec 2011

 Change of Director's Interest Notice

 08 Dec 2011

 Change of Director's Interest Notice

 02 Dec 2011

 Dispatch of Rights Issue Holdings Statements

 01 Dec 2011

 Completed Midkine Study for Normal Reference Range

 29 Nov 2011

 Rights Issue and Placement of Shortfall

 25 Nov 2011

 Amended Constitution

 25 Nov 2011

 Results of Meeting

 14 Nov 2011

 US Patent for the Prevention or Treatment of Ischemia

 09 Nov 2011

 Non-Renounceable Rights Issue Despatch of Offer Document

 31 Oct 2011

 Appendix 4C

 27 Oct 2011

 Pro Forma Appendix 3B

 26 Oct 2011

 Annual Report to Shareholders

 26 Oct 2011

 Notice of Annual General Meeting / Proxy Form

 26 Oct 2011

 Non-Renounceable Rights Issue

 20 Oct 2011

 Amended Constitution of November 2008

 12 Oct 2011

 CE Marking of Cellmid's Midkine ELISA

 06 Oct 2011

 Completed Humanisation of First Ever Anti-midkine Antibody

 30 Sep 2011

 Results of meeting

 30 Sep 2011

 EGM Presentation by the CEO

 31 Aug 2011

 Notice of Extraordinary General Meeting Proxy

 29 Aug 2011

 Appendix 4E and Preliminary Final Report

 17 Aug 2011

 Change of Director's Interest Notice

 02 Aug 2011

 Completed GMP Manufacture of Midkine Test

 25 July 2011

 Appendix 4C

 10 June 2011

 Appendix 3B

 31 May 2011

 Change of Director's Interest Notice

 25 May 2011

 Celera license update

 19 Apr 2011

 Appendix 4C - quarterly

 14 Apr 2011

 Appendix 3B

 13 Apr 2011

 Cellmid Signs Antibody Humanisation Collaboration

 11 Apr 2011

 Completion of Proof of Concept Study for Heart Attack

 16 Apr 2011

 Appendix 3B

 16 Mar 2011

 Update on Cellmid's Japanese Operations

 15 Mar 2011

 Change of Director's Interest Notice

 07 Mar 2011

 Change of Director's Interest Notice

 22 Feb 2011

 Cellmid News

 22 Feb 2011

 Appendix 4D and Half Year Accounts

 18 Feb 2011

 Change of Director's Interest Notice

 02 Feb 2011

 Appendix 3B

 31 Jan 2011

 Appendix 4C - quarterly

 10 Jan 2011

 Appendix 3B

 05 Jan 2011

 Cellmid Share Trading Policy